Imboost Producer Earns Profit Because Of Pandemic, Soho Global Health Earned IDR 6.16 Trillion In Sales In 2020

Imboost. (Photo: Shopee)

JAKARTA - The pharmaceutical company, PT Soho Global Health Tbk (SOHO) recorded positive financial performance throughout 2020. This health supplement company that produces Imboost received blessings from the COVID-19 pandemic by generating a net income of IDR 6.16 trillion in 2020.

Quoted from the disclosure of information on the Indonesia Stock Exchange (IDX) website, Wednesday, March 31, this achievement increased by 22.22 percent (year on year/yoy) compared to the previous year's net income realization of IDR 5.04 trillion.

SOHO's net income in 2020, the majority came from the distribution business segment, amounting to IDR 4.64 trillion. Then followed by revenue from the professional products business segment amounting to IDR 568.65 billion, the consumer health business segment amounting to IDR 523.22 billion, other business segments amounting to IDR 344.01 billion, and the alliance business segment amounting to IDR 79.05 billion.

SOHO's cost of revenue increased by 19.35 percent (yoy) from IDR 4.03 trillion in 2019 to IDR 4.81 trillion in 2020. SOHO selling expenses also increased by 14.60 percent (yoy) from IDR 580.76 billion in 2019 to IDR 665.57 billion.

As a result, SOHO obtained a net profit attributable to the owners of the main entity amounting to IDR 172.10 billion at the end of 2020. This number jumped 45.29 percent (yoy) compared to the company's net profit in 2019 of IDR 118.45 billion.

SOHO's total assets by the end of 2020 were recorded at IDR 4.18 trillion, an increase of 28.22 percent (yoy) of the company's total assets in 2019 of IDR 3.26 trillion. SOHO's asset value last year was divided into total liabilities of IDR 1.97 trillion and total equity of IDR 2.20 trillion.